Zoekresultaten - Kelly L. Harms, MD, PhD

Circulating tumor DNA is a useful adjunct for Merkel cell carcinoma monitoring in the context of multiple metastatic malignancies door Daniel Wenzel, MD, Andrew M. Schuler, MD, David C. Smith, MD, Joseph R. Evans, MD, PhD, Kelly L. Harms, MD, PhD, Elisabeth A. Pedersen, MD, PhD

Connect to this object online.

Unknown primary Merkel cell carcinoma in the immunosuppressed patient: Case series door Jason M. Rizzo, MD, PhD, Paul W. Harms, MD, PhD, Kelly L. Harms, MD, PhD, Andrew Plaska, MD, Chad Brenner, PhD, Alison B. Durham, MD

Connect to this object online.